Yield10 Bioscience, Inc. (formerly Metabolix, Inc.) is focused on developing disruptive technologies for step-change improvements in crop yield. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing several yield traits in development in crops such as camelina, canola, soybean, rice and corn. The Company is based in Woburn, Mass.
Whether you are a long-time shareholder or just beginning to consider an investment in our company, we are committed to providing you with useful information and convenient tools you need to make informed decisions about your investment.
Investors should note that we announce material information to our investors using our website, SEC filings, press releases, public conference calls and webcasts. We use these channels, as well as social media, to communicate with our shareholders and the public about our company, our products and other matters. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company to review the information we post on the social media channels listed at the top of our website.
View all » Recent Releases
View all »Events & Presentations
Jul 31, 2017
Video Interview with Dr. Oliver Peoples
Listen to webcast
Jun 27, 2017
Plant Biology 2017
View Presentation 1.1 MB
View all »Recent SEC Filings
|10-Q||quarterly report||Aug 11, 2017|
|8-K||current report||Aug 10, 2017|
|4||schuler, jack w||Aug 2, 2017|
|SC 13D||general statement of beneficial ownership||Aug 2, 2017|
|D||small company offering and sale of securities without registration||Jul 14, 2017|
|424B5||prospectus filed pursuant to rule 424||Jul 6, 2017|
View all »Quarterly Results
|Second Quarter 2017|
|Yield10 Bioscience Second Quarter 2017 Earnings Call|
|Yield10 Bioscience Announces Second Quarter 2017 Financial Results|